应用HLA-EMMA在9/10位点不合无关供者儿童干细胞移植中判定可允许HLA错配:EBMT先天错误工作组研究
该研究在70例儿童9/10位点不合无关供者移植和157例10/10相合无关供者移植中,用HLA表位错配算法评估氨基酸匹配;宿主抗移植物方向α螺旋匹配者无事件生存率与10/10相合供者相似,并在EBMT注册组271例9/10和929例10/10移植中重现。
要点
- 宿主抗移植物方向总氨基酸匹配者1年无事件生存率92% vs 58%(P=.009)。
- 宿主抗移植物方向α螺旋匹配者1年无事件生存率90% vs 53%(P=.002)。
- α螺旋匹配的9/10移植与10/10相合移植无事件生存率90% vs 80%(P=.60)。
核心结论
- 宿主抗移植物方向α螺旋氨基酸匹配可识别9/10位点不合无关供者中的可允许错配,其移植结局与相合供者相似。
研究设计与样本
- 单中心队列纳入70例儿童9/10位点不合无关供者造血干细胞移植,并与157例10/10相合无关供者移植比较。
- 在EBMT注册先天错误队列中验证,包括271例儿童9/10位点不合无关供者移植和929例10/10相合无关供者移植。
- 采用HLA表位错配算法,评估全HLA蛋白、α螺旋和β折叠的氨基酸匹配,分宿主抗移植物和移植物抗宿主两个方向。
主要发现
- 宿主抗移植物方向总氨基酸匹配的13例患者1年无事件生存率92% vs 58%(P=.009)。
- 宿主抗移植物方向α螺旋匹配的21例患者1年无事件生存率90% vs 53%(P=.002)。
- α螺旋匹配的9/10移植与10/10相合移植1年无事件生存率90% vs 80%(P=.60)。
- 无事件生存率与β折叠氨基酸匹配及移植物抗宿主方向匹配无关。
- 总生存率趋势与无事件生存率相似:总氨基酸匹配92% vs 74%(P=.075),α螺旋匹配90% vs 71%(P=.072)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic hematopoietic stem cell transplantation (HSCT) with mismatched unrelated donors (MMUD) is associated with inferior outcome compared with matched unrelated donors (MUDs). We aimed to identify permissible mismatches using HLA epitope mismatch algorithm, which determines permissibility by analyzing amino acid sequences, in a single-center cohort of 70 pediatric 9/10 MMUD HSCTs and 157 10/10 MUDs for comparison. Amino acid matching was evaluated for the whole HLA protein, the α-helices, and the β-sheets, in both host vs graft (HvG) and graft vs host (GvH) direction. Superior event-free survival (EFS) was found in 13 patients permissibly mismatched in the HvG direction (totalHvG, 92% vs 58% at 1 year; P = .009) and in 21 patients matched on the α-helices (αHvG, 90% vs 53%; P = .002). These rates were similar to EFS rates in patients with 10/10 MUDs (90% vs 80%; P = .60). EFS was not related to β-sheet amino acid matching, nor to matching in the GvH direction. Overall survival (OS) rates trended similarly to those of EFS for amino acid mismatches (totalHvG, 92% vs 74%; P = .075; αHvG, 90% vs 71%; P = .072). These findings were reproduced in an EBMT Registry inborn errors cohort of 271 pediatric 9/10 MMUD HSCTs and 929 10/10 MUD HSCTs, showing a significant effect of αHvG matching on both OS and EFS and similar OS and EFS between αHvG matched MMUDs and 10/10 MUDs. In summary, HvG amino acid matching on the α-helices identifies 9/10 MMUDs with permissible mismatches, which are correlated with favorable transplant outcomes similar to those of matched donors.
引用
- von Asmuth EGJ, Hiensch F, Heidt S, et al. Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party study. Blood Adv. 2024. PMID: 38985189. doi:10.1182/bloodadvances.2024012945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。